Precisión diagnóstica de la imagenología para la detección de metástasis en los ganglios linfáticos cervicales centrales y laterales en el carcinoma papilar de tiroides
Introduction: Papillary thyroid carcinoma (PTC) presents cervical lymph node metastases in 20-50% of cases, and preoperative detection determines surgical extent (Su et al., 2024). Conventional ultrasound identifies suspicious adenopathy in only 20-31% of cases, especially in the central compartment (Su et al., 2024). Over the past two decades, the transition from conventional ultrasound to advanced modalities (CEUS, SRUS, radiomics) has transformed the diagnostic paradigm (Fan et al., 2026). Objective: To synthesize evidence on the diagnostic accuracy of imaging modalities for central and lateral lymph node metastases in PTC, evaluating technological evolution and performing a quantitative analysis of outcomes. Methods: Exploratory systematic review following PRISMA 2020 (Page et al., 2021). Three PICO questions were formulated. Search in PubMed/MEDLINE, Europe PMC, Scopus, and Web of Science (January 2005 to October 2026). Studies with histopathological confirmation reporting sensitivity, specificity, or AUC were included. Quantitative analysis of diagnostic accuracy metrics was performed. Results: Seventy-eight records were identified; after screening, 9 studies were included (2005-2026). For the central compartment, quantitative CEUS (PI ratio ≥1) showed the best performance (AUC 0.831; 95% CI: 0.78-0.88) versus conventional ultrasound (AUC 0.707) (Su et al., 2024). For the lateral compartment, the multimodal US+CEUS+SRUS model achieved an AUC of 0.961 (95% CI: 0.933-0.988), comparable to FNA-Tg (AUC 0.961; p=0.989) and superior to FNAC (AUC 0.858; p<0.001) (Fan et al., 2026). Meta-analysis of radiomics models (60 studies) reported a pooled AUC of 0.83 for radiomics alone and 0.88 for combined models (Nabavizadeh et al., 2026). Conclusions: The technological transition from conventional ultrasound to quantitative CEUS and SRUS has significantly improved diagnostic accuracy, with performance approaching the non-histological reference standard (FNA-Tg). Methodological heterogeneity persists, and external validation of multimodal models is essential before widespread clinical implementation.
Authors
- José David Tello Ochoa (ORCID: https://orcid.org/0000-0003-3922-9702)
- Bryan Andrés Cóndor Coraquilla (ORCID: https://orcid.org/0000-0002-7348-1349)
- Juliana del Rocio Carrasco Lascano (ORCID: https://orcid.org/0000-0003-3635-8955)
- Luis David Torres Estrada (ORCID: https://orcid.org/0009-0002-9918-3697)
- Rommel Francisco Portilla Araujo (ORCID: https://orcid.org/0009-0003-4078-5551)
Publication Details
- Journal
- Salud Medicina e Innovación Journal
- Published
- 2026-11-19
- DOI
- https://doi.org/10.70577/vp1nkk67
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00